当前位置：首页 > 文献互助 > 互助详情

DNA-compatible chemistry for DNA-encoded libraries and beyond复制

用户Nu8mH6TzmV5Q 13天前 38 10 已完结

1. 系统已在2025-11-25 16:18:34对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

W Hou, S Zhang, W Yi, P Ma, H Xu
Trends in Chemistry, 2025
cell.com
DNA-encoded libraries (DELs) have emerged as a critical technology for rapid hit identification in drug discovery. The effectiveness of DEL selection fundamentally depends …

上一篇： In vivo CAR-T cell therapy and its technologies: A perspective

下一篇：成人心脏手术围手术期用药专家共识（2025版）

互助时间线

2025-11-18 16:28:18 [完结求助]

楼主确认了jodie0105应助的文件是正确的, 求助状态变成 已完结

2025-11-18 16:18:34 [上传文件]

jodie0105上传了文件(pdf 2.34 MB), 求助状态变成 待确认

2025-11-18 14:09:20 [发起求助]

最新发布的求助

Index Structures for Biological Sequences 1小时前
Drugging the efferocytosis process: concepts and opportunities. 2小时前
Characterization of CAR-T cellular kinetics and efficacy in solid tumor patients with and without prior lymphodepletion chemotherapy using a PBPK-PD model 4小时前
Comprehensive 3d Transition Metal Single‐Atom Modulation Tunes Ni‐MOF D‐Band for Alkaline OER 4小时前
Decoupling of nitrogen, phosphorus, and carbon release from fine and coarse roots during 7 years of decomposition 5小时前
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure 5小时前
Tetrahedral Framework Nucleic Acid-Based Delivery of miR-34a Inhibitor for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis. 5小时前
A practical guide to large-scale docking 6小时前
Bicyclo[1.1.1]pentane-Derived Building Blocks for Click Chemistry 6小时前
Expanding Therapeutic Horizons in Parkinson's Disease Through MicroRNA-Based Interventions: A Comprehensive Review 6小时前
{Formulated Preparations- Specific Monographs} Rivastigmine Capsules - british pharmacopoeia[1731412457.779041.html] 7小时前
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China 8小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com